Atherosclerosis  >>  icosapent ethyl  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
icosapent ethyl / Generic mfg.
EPA&LDL, NCT04152291: The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism

Unknown status
N/A
50
Europe
Ethyl-Eicosapentaenoic Acid (E-EPA), E-EPA, Icosapentaenoic acid
Wihuri Research Institute, University of Helsinki, Karolinska Institutet, Minerva Foundation Institute for Medical Research
Atherosclerosis, Low-density Lipoproteins Aggregation Susceptibility, Low-density Lipoprotein Lipid Composition, Cardiovascular Diseases
05/20
12/20

Download Options